Neurovascular Devices / Interventional Neurology Market
Market Insights on Neurovascular Devices/ Interventional Neurology covering sales outlook, demand forecast & up-to-date key trends
Neurovascular Devices/ Interventional Neurology Market by Product, Disease Pathology, End User & Region - Forecast 2022 – 2032
Neurovascular Devices/ Interventional Neurology Market Outlook (2022-2032)
[324 Pages Report] The neurovascular devices market share is anticipated to grow with a CAGR of 8.5% from 2022 to 2032. The neurovascular devices market size is likely to raise up to US$ 2.7 Bn in 2022. Increasing demand for interventional neurology due to rising neurological disorders, which are likely to generate a neurovascular devices market growth of US$ 6.2 Bn by 2032.
“Rising in demand for neurovascular devices/ interventional neurology devices due to increasing population of neurological disorders patients which includes various types of central nervous system disorders & treat various types of peripheral.”
|
Attributes |
Details |
|
Neurovascular Devices/ Interventional Neurology Market CAGR (2022-2032) |
8.5% |
|
Neurovascular Devices/ Interventional Neurology Market Size (2022) |
US$ 2.7 Bn |
|
Neurovascular Devices/ Interventional Neurology Market Size (2032) |
US$ 6.2 Bn |
The sales of interventional neurology devices are likely to rise due to brain aneurysm disorder & widely used for neurovascular disorders such as clips, coils & stents.
The adoption of interventional neurology devices is estimated to raise the interventional neurology market growth in the coming forecast period from 2022 to 2032.
The high advancement in the medical field related to neurovascular disorders is generating huge demand for neurovascular devices. This is likely to propel the interventional neurology market share during the forecast period.
Some common additional aid treated by neurovascular devices are fistulas, aneurysms, arteriovenous malformation, etc. are likely to rise the interventional neurology devices market size.
Neurovascular devices are likely to rise in end-user industries such as Hospitals & Surgical Centers, Ambulatory Care Centers, Research Laboratories & Academic Institutes, and others which will increase the interventional neurology devices market growth.
The sales of neurovascular devices are rising due to an increase in demand by end-users. Leading countries such as China, the US, Japan, India, and Germany like to increase their lion’s share in the coming year.
The manufacturers are increasing the production of devices to provide treatment across the countries & around the world, which leads to a rising the interventional neurology devices market share during the forecast period from 2022 to 2032.
Let us know your requirement to get
100% FREE customization
What is the COVID-19 Impact on Neurovascular Devices Market?
The COVID-19 waves affect almost all industries and put a negative impact on medical treatment devices which is likely to reduce the significant growth of the interventional neurology devices market size.
The last two years have been worst for every person, especially for the patient that rushes to the hospital in an emergency during the COVID-19 crisis. Most patients avoided hospitals, clinics, and other healthcare sectors during the pandemic all around the region.
Patients with various critical diseases, including myocardial infarction, cancer, and stroke, were not preferring to go to hospitals during the pandemic of COVID-19 situations, which falls in the neurovascular devices/ interventional neurology devices market growth.
Due to the unavailability of medical devices, the various surgeries and treatments were postponed as the manufacturers closed the production temporarily due to lockdown situations. It also affects the supply chain, which is likely to reduce the sales of neurovascular devices/ interventional neurology devices.
What are the Key Interventional Neurology Market Dynamics?
The interventional neurology market is anticipated to grow by the key dynamic end-user manufacturing companies, which play a vital role in the enlarging of the interventional neurology market size during the forecast period from 2022 to 2032.
Several industries are contributing to the interventional neurology market growth by collaborating, partnership & merges. They adopt various methods, strategies, and techniques to lift the market and boost the economy all around the region.
Some of the key dynamics industries are Hospitals & Surgical Centers, Ambulatory Care Centers, Research Laboratories & Academic Institutes, and others that are likely to rise the revenue of neurovascular devices/ interventional neurology devices as per the neurovascular devices market report.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystComparative View of Adjacent Neurovascular Devices Market
Neurovascular Devices Market/ Interventional Neurology Market:
|
Attributes |
Neurovascular Devices Market/ Interventional Neurology Market |
|
CAGR (2022-2032) |
8.5% |
|
Market Value (2022) |
US$ 2.7 Billion |
|
Growth Factor |
Rising number of neurovascular disorder patient. |
|
Opportunity |
Faster patient recovery, higher procedural safety & efficacy, and greater affordability. |
|
Key Trends |
To growing in adoption of Hi-tech devices & provide better procedures related neurovascular disorder. |
Laser Therapy Market:
|
Attributes |
Laser Therapy Market |
|
CAGR (2022-2032) |
4% |
|
Market Value (2022) |
US$ 2 billion |
|
Growth Factor |
Due to power output, frequency, dose are generating the growth of laser therapy. |
|
Opportunity |
Low intensity laser light, relieve pain, repair & restore the cell function. |
|
Key Trends |
To adopt the high advancement. |
Orthopedic Devices Market:
|
Attributes |
Orthopedic Devices Market |
|
CAGR (2022-2032) |
3.1% |
|
Market Value (2022) |
US$ 42.3 Billion |
|
Growth Factor |
Rising in demand due to increasing in the number of joint, bone damaged. |
|
Opportunity |
Implant the bone using fabrication, replace the missing bone or joints, pain freely. |
|
Key Trends |
Improve product innovation, control cost and reduce surgery time. |
The above table is all about the comparative adjacent of the neurovascular devices market with the laser therapy market & orthopedic device market. It clears the growth factor, opportunities & key trends of all these markets during the forecast period from 2022 to 2032.
The neurovascular devices/ interventional neurology market is improving the market with its new innovative devices to overcome the burden on doctors as well as patients. It saves time and treats your illness with minimal time, which raised the demand for the adoption of neurovascular devices in the marketplace.
The US is expecting the leading country in the adoption of interventional neurology devices all around the globe, with the highest CAGR of 8.4% through 2032. The historical CAGR of interventional neurology market share was US$ 2.5 Billion in 2021.
The various competitors are growing the market with their several plans and policies as per the interventional neurology market report. All these factors are likely to increase the demand for neurovascular devices & also increase the sales of neurovascular devices in the coming year.
Which Segment Dominates the Neurovascular Devices Market, by Product?
Based on product, the aneurysm coiling & embolization devices segment is anticipated to dominate the interventional neurology market size with a CAGR of 8.1% during the forecast period from 2022 to 2032.
The aneurysm coiling & embolization devices are wide uses to induce clotting during endovascular coiling & preventing blood from getting into, which is likely to rise the aneurysm coiling & embolization devices market size. It is likely to expand the interventional neurology market business in the forthcoming year.
This process is led in several hospitals, surgical centers, research laboratories, and others which increase the aneurysm coiling & embolization devices market growth in the coming forecast period from 2022 to 2032.
The aneurysm coiling & embolization devices segment is one of the best solutions to lead the patient during the forecast period.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Which Segment is Likely to Lead the Neurovascular Devices Market, by Disease Pathology?
Based on disease pathology, the cerebral aneurysms segment is anticipated to lead the interventional neurology market trends with a CAGR of 8.3% during the forecast period from 2022 to 2032.
It is one of the common treatments which provides therapy, surgery, and endovascular treatments, which are likely to rise the interventional neurology devices in the market.
What is the Regional Analysis for the Interventional Neurology Market?
| Region | Historic CAGR (2015-2021) |
| US Market Size | 8.8% |
| UK Market Size | 8.2% |
| China Market Size | 8.6% |
| Japan Market Size | 7.7% |
| South Korea Market Size | 6.8% |
| Region | CAGR (2022-2032) |
| US Market Size | 8.4% |
| UK Market Size | 7.5% |
| China Market Size | 8.1% |
| Japan Market Size | 7.2% |
| South Korea Market Size | 6.1% |
The interventional neurology market share is anticipated to divide into regions including North America, Europe, Asia-Pacific, Africa, the Middle East, and Latin America. The North American region is anticipated to dominate the neurovascular devices market size in the forecast period from 2022 to 2032.
The leading country US, is anticipated to boost with the highest CAGR of 8.4% during the forecast period from 2022 to 2032. Due to rising in neurology procedures and emergency facilities and the increasing trauma likely to rise in the adoption of neurovascular devices in the US.
The China market is the second most prominent market all around the globe in the adoption of interventional neurology. China is estimated to increase its market revenue with a CAGR of 8.1% during the forecast period from 2022 to 2032.
Due to the number of hospitals, research laboratories, and the production of neurovascular devices are expanding in China which rising interventional neurology market key trend & opportunity.
UK is also acquiring a CAGR of 7.5% in the neurovascular devices market as per the interventional neurology market survey during the forecast period from 2022 to 2032.
Other regions, such as Japan and South Korea, are anticipated to rise in the neurovascular devices market statistics. All regions are enlarging the interventional neurology market globally during the forecast period from 2022 to 2032.
What is the Competition in the Neurovascular Devices Market Market?
The key competitor companies in the interventional neurology market are likely to rise in the devices production and consumption of use which increases the neurovascular devices market size during the forecast period.
Some of the competitive companies are Johnson & Johnson, Medtronic PLC, Stryker Corporation, Terumo Corporation, Penumbra, and others rising interventional neurology market future trends.
Recent Developments in the Neurovascular Devices Market
Johnson & Johnson launched the new product of stroke solutions (2020) known as Cerenovus stroke solutions which helps in removing clot procedures. The device is the big bore catheter, emo trap 3 revascularization device.
Penumbra company partnered with the Genesis MedTech company to rise the neurovascular market size in China (2021).
The Pehnox established its new entity in the UK to rise in the neurovascular market size in the Europe region.
Key Segments
By Product:
- Aneurysm Coiling & Embolization Devices
- Cerebral Balloon Angioplasty
- Stentiny Systems
- Support Devices
- Neurothrombectomy Devices
By Disease Pathology:
- Ischemic Strokes
- Cerebral Aneuryms
- Cartotid Artery Stenosis
- Arteriovenous Malformations
- Fistulas
- Others
By End-User:
- Hospitals & Surgical Centers
- Ambulatory Care Centers
- Research Laboratories
- Academic Institutes
By Region:
- North America
- Asia Pacific
- Europe
- Middle East & Africa
- Latin America
Frequently Asked Questions
The interventional neurology market is estimated to register a CAGR of 8.5%, during the forecast period (2022 - 2032).
During the projected period, the U.S. is expected to lead the neurovascular devices by 2032.
By product, the aneurysm coiling & embolization devices segment is dominating over the forecast period.
The interventional neurology market is expected to be valued at US$ 6.2 Billion by 2032.
The interventional neurology market accounted for around US$ 2.5 Billion in 2021.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Management Market, by Key Countries
4.2. Management Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Management Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Management Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Market Demand Analysis 2015-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Market Value Analysis 2015-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product, 2015-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022-2032
8.3.1. Aneurysm coiling & embolization devices
8.3.2. Cerebral balloon angioplasty & Stenting systems
8.3.3. Support devices
8.3.4. Neurothrombectomy devices
8.4. Market Attractiveness Analysis By Product
9. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Disease pathology
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Disease pathology, 2015-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease pathology, 2022-2032
9.3.1. Ischemic Strokes
9.3.2. Cerebral Aneuryms
9.3.3. Carotid Artery Stenosis
9.3.4. Arteriovenous Malformations and Fistulas
9.3.5. Others
9.4. Market Attractiveness Analysis By Disease pathology
10. Global Market Analysis 2015-2021 and Forecast 2022-2032, By End-User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By End-User, 2015-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-User, 2022-2032
10.3.1. Hospitals & surgical centers
10.3.2. Ambulatory care centers
10.3.3. Research laboratories & academic institutes
10.4. Market Attractiveness Analysis By End-User
11. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021
11.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. Asia Pacific
11.3.5. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Market Analysis 2015-2021 and Forecast 2022-2032
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
12.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
12.4.1. By Country
12.4.1.1. U.S.
12.4.1.2. Canada
12.4.1.3. Rest of North America
12.4.2. By Product
12.4.3. By End-User
12.4.4. By Disease pathology
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product
12.5.3. By End-User
12.5.4. By Disease pathology
13. Latin America Market Analysis 2015-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
13.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. Brazil
13.4.1.2. Mexico
13.4.1.3. Rest of Latin America
13.4.2. By Product
13.4.3. By End-User
13.4.4. By Disease pathology
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product
13.5.3. By End-User
13.5.4. By Disease pathology
14. Europe Market Analysis 2015-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
14.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. Germany
14.4.1.2. France
14.4.1.3. U.K.
14.4.1.4. Italy
14.4.1.5. Benelux
14.4.1.6. Nordic Countries
14.4.1.7. Rest of Europe
14.4.2. By Product
14.4.3. By End-User
14.4.4. By Disease pathology
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product
14.5.3. By End-User
14.5.4. By Disease pathology
15. Asia Pacific Market Analysis 2015-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
15.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. China
15.4.1.2. Japan
15.4.1.3. South Korea
15.4.1.4. Rest of Asia Pacific
15.4.2. By Product
15.4.3. By End-User
15.4.4. By Disease pathology
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product
15.5.3. By End-User
15.5.4. By Disease pathology
16. Middle East and Africa Market Analysis 2015-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
16.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. GCC Countries
16.4.1.2. South Africa
16.4.1.3. Turkey
16.4.1.4. Rest of Middle East and Africa
16.4.2. By Product
16.4.3. By End-User
16.4.4. By Disease pathology
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product
16.5.3. By End-User
16.5.4. By Disease pathology
17. Key Countries Market Analysis 2015-2021 and Forecast 2022-2032
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. US Market Analysis
17.2.1. Value Proportion Analysis by Market Taxonomy
17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.2.2.1. By Product
17.2.2.2. By End-User
17.2.2.3. By Disease pathology
17.3. Canada Market Analysis
17.3.1. Value Proportion Analysis by Market Taxonomy
17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.3.2.1. By Product
17.3.2.2. By End-User
17.3.2.3. By Disease pathology
17.4. Mexico Market Analysis
17.4.1. Value Proportion Analysis by Market Taxonomy
17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.4.2.1. By Product
17.4.2.2. By End-User
17.4.2.3. By Disease pathology
17.5. Brazil Market Analysis
17.5.1. Value Proportion Analysis by Market Taxonomy
17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.5.2.1. By Product
17.5.2.2. By End-User
17.5.2.3. By Disease pathology
17.6. Germany Market Analysis
17.6.1. Value Proportion Analysis by Market Taxonomy
17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.6.2.1. By Product
17.6.2.2. By End-User
17.6.2.3. By Disease pathology
17.7. France Market Analysis
17.7.1. Value Proportion Analysis by Market Taxonomy
17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.7.2.1. By Product
17.7.2.2. By End-User
17.7.2.3. By Disease pathology
17.8. Italy Market Analysis
17.8.1. Value Proportion Analysis by Market Taxonomy
17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.8.2.1. By Product
17.8.2.2. By End-User
17.8.2.3. By Disease pathology
17.9. BENELUX Market Analysis
17.9.1. Value Proportion Analysis by Market Taxonomy
17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.9.2.1. By Product
17.9.2.2. By End-User
17.9.2.3. By Disease pathology
17.10. UK Market Analysis
17.10.1. Value Proportion Analysis by Market Taxonomy
17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.10.2.1. By Product
17.10.2.2. By End-User
17.10.2.3. By Disease pathology
17.11. Nordic Countries Market Analysis
17.11.1. Value Proportion Analysis by Market Taxonomy
17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.11.2.1. By Product
17.11.2.2. By End-User
17.11.2.3. By Disease pathology
17.12. China Market Analysis
17.12.1. Value Proportion Analysis by Market Taxonomy
17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.12.2.1. By Product
17.12.2.2. By End-User
17.12.2.3. By Disease pathology
17.13. Japan Market Analysis
17.13.1. Value Proportion Analysis by Market Taxonomy
17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.13.2.1. By Product
17.13.2.2. By End-User
17.13.2.3. By Disease pathology
17.14. South Korea Market Analysis
17.14.1. Value Proportion Analysis by Market Taxonomy
17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.14.2.1. By Product
17.14.2.2. By End-User
17.14.2.3. By Disease pathology
17.15. GCC Countries Market Analysis
17.15.1. Value Proportion Analysis by Market Taxonomy
17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.15.2.1. By Product
17.15.2.2. By End-User
17.15.2.3. By Disease pathology
17.16. South Africa Market Analysis
17.16.1. Value Proportion Analysis by Market Taxonomy
17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.16.2.1. By Product
17.16.2.2. By End-User
17.16.2.3. By Disease pathology
17.17. Turkey Market Analysis
17.17.1. Value Proportion Analysis by Market Taxonomy
17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.17.2.1. By Product
17.17.2.2. By End-User
17.17.2.3. By Disease pathology
17.17.3. Competition Landscape and Player Concentration in the Country
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
18.4. Market Presence Analysis
18.4.1. By Regional footprint of Players
18.4.2. Product footprint by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. Johnson & Johnson
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Sales Footprint
19.3.1.4. Strategy Overview
19.3.2. Medtronic PLC
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Sales Footprint
19.3.2.4. Strategy Overview
19.3.3. Stryker Corporation
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Sales Footprint
19.3.3.4. Strategy Overview
19.3.4. Terumo Corporation
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Sales Footprint
19.3.4.4. Strategy Overview
19.3.5. Penumbra, Inc.
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Sales Footprint
19.3.5.4. Strategy Overview
19.3.6. Microport Scientific Corporation
19.3.6.1. Overview
19.3.6.2. Product Portfolio
19.3.6.3. Sales Footprint
19.3.6.4. Strategy Overview
19.3.7. Kaneka Corp.
19.3.7.1. Overview
19.3.7.2. Product Portfolio
19.3.7.3. Sales Footprint
19.3.7.4. Strategy Overview
19.3.8. Integer Holdings Corporation, Balt
19.3.8.1. Overview
19.3.8.2. Product Portfolio
19.3.8.3. Sales Footprint
19.3.8.4. Strategy Overview
20. Assumptions and Acronyms Used
21. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Market Value (US$ Mn), By Product, 2015 – 2021
Table 2: Global Market Value (US$ Mn), By Product, 2022 – 2032
Table 3: Global Market Value (US$ Mn), By End-User, 2015 – 2021
Table 4: Global Market Value (US$ Mn), By End-User, 2022 – 2032
Table 5: Global Market Value (US$ Mn), By Disease pathology, 2015 – 2021
Table 6: Global Market Value (US$ Mn), By Disease pathology, 2022 – 2032
Table 7: Global Market, By Region, 2015 – 2021
Table 8: Global Market, By Region, 2022 – 2032
Table 9: North America Market Value (US$ Mn), By Product, 2015 – 2021
Table 10: North America Market Value (US$ Mn), By Product, 2022 – 2032
Table 11: North America Market Value (US$ Mn), By End-User, 2015 – 2021
Table 12: North America Market Value (US$ Mn), By End-User, 2022 – 2032
Table 13: North America Market Value (US$ Mn), By Disease pathology, 2015 – 2021
Table 14: North America Market Value (US$ Mn), By Disease pathology, 2022 – 2032
Table 15: North America Market, By Country, 2015 – 2021
Table 16: North America Market, By Country, 2022 – 2032
Table 17: Latin America Market Value (US$ Mn), By Product, 2015 – 2021
Table 18: Latin America Market Value (US$ Mn), By Product, 2022 – 2032
Table 19: Latin America Market Value (US$ Mn), By End-User, 2015 – 2021
Table 20: Latin America Market Value (US$ Mn), By End-User, 2022 – 2032
Table 21: Latin America Market Value (US$ Mn), By Disease pathology, 2015 – 2021
Table 22: Latin America Market Value (US$ Mn), By Disease pathology, 2022 – 2032
Table 23: Latin America Market, By Country, 2015 – 2021
Table 24: Latin America Market, By Country, 2022 – 2032
Table 25: Europe Market Value (US$ Mn), By Product, 2015 – 2021
Table 26: Europe Market Value (US$ Mn), By Product, 2022 – 2032
Table 27: Europe Market Value (US$ Mn), By End-User, 2015 – 2021
Table 28: Europe Market Value (US$ Mn), By End-User, 2022 – 2032
Table 29: Europe Market Value (US$ Mn), By Disease pathology, 2015 – 2021
Table 30: Europe Market Value (US$ Mn), By Disease pathology, 2022 – 2032
Table 31: Europe Market, By Country, 2015 – 2021
Table 32: Europe Market, By Country, 2022 – 2032
Table 33: Asia Pacific Market Value (US$ Mn), By Product, 2015 – 2021
Table 34: Asia Pacific Market Value (US$ Mn), By Product, 2022 – 2032
Table 35: Asia Pacific Market Value (US$ Mn), By End-User, 2015 – 2021
Table 36: Asia Pacific Market Value (US$ Mn), By End-User, 2022 – 2032
Table 37: Asia Pacific Market Value (US$ Mn), By Disease pathology, 2015 – 2021
Table 38: Asia Pacific Market Value (US$ Mn), By Disease pathology, 2022 – 2032
Table 39: Asia Pacific Market, By Country, 2015 – 2021
Table 40: Asia Pacific Market, By Country, 2022 – 2032
Table 41: MEA Market Value (US$ Mn), By Product, 2015 – 2021
Table 42: MEA Market Value (US$ Mn), By Product, 2022 – 2032
Table 43: MEA Market Value (US$ Mn), By End-User, 2015 – 2021
Table 44: MEA Market Value (US$ Mn), By End-User, 2022 – 2032
Table 45: MEA Market Value (US$ Mn), By Disease pathology, 2015 – 2021
Table 46: MEA Market Value (US$ Mn), By Disease pathology, 2022 – 2032
Table 47: MEA Market, By Country, 2015 – 2021
Table 48: MEA Market, By Country, 2022 – 2032
Table 49: Global Market Incremental $ Opportunity, By Product, 2015 - 2021
Table 50: Global Market Incremental $ Opportunity, By End-User, 2022 – 2032
Table 51: Global Market Incremental $ Opportunity, By Disease pathology, 2015 - 2021
Table 52: Global Market Incremental $ Opportunity, By Region, 2022 – 2032
Table 53: North America Market Incremental $ Opportunity, By Product, 2015 - 2021
Table 54: North America Market Incremental $ Opportunity, By End-User, 2022 – 2032
Table 55: North America Market Incremental $ Opportunity, By Disease pathology, 2015 – 2021
Table 56: North America Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 57: Latin America Market Incremental $ Opportunity, By Product, 2015 - 2021
Table 58: Latin America Market Incremental $ Opportunity, By End-User, 2022 – 2032
Table 59: Latin America Market Incremental $ Opportunity, By Disease pathology, 2015 - 2021
Table 60: Latin America Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 61: Europe Market Incremental $ Opportunity, By Product, 2015 - 2021
Table 62: Europe Market Incremental $ Opportunity, By End-User, 2022 – 2032
Table 63: Europe Market Incremental $ Opportunity, By Disease pathology, 2015 - 2021
Table 64: Europe Market Incremental $ Opportunity, By Country, 2022 - 2032
Table 65: Asia Pacific Market Incremental $ Opportunity, By Product, 2015 - 2021
Table 66: Asia Pacific Market Incremental $ Opportunity, By End-User, 2022 – 2032
Table 67: Asia Pacific Market Incremental $ Opportunity, By Disease pathology, 2015 - 2021
Table 68: Asia Pacific Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 69: MEA Market Incremental $ Opportunity, By Product, 2015 - 2021
Table 70: MEA Market Incremental $ Opportunity, By End-User, 2022 – 2032
Table 71: MEA Market Incremental $ Opportunity, By Disease pathology, 2015 - 2021
Table 72: MEA Market Incremental $ Opportunity, By Country, 2022 - 2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 2: Global Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 3: Global Market Share, By Product, 2022 & 2032
Figure 4: Global Market Y-o-Y Growth Projections, Type – 2022-2032
Figure 5: Global Market Attractiveness Index, Type – 2022-2032
Figure 6: Global Market Share, By End-User, 2022 & 2032
Figure 7: Global Market Y-o-Y Growth Projections, By End-User – 2022-2032
Figure 8: Global Market Attractiveness Index, By End-User – 2022-2032
Figure 9: Global Market Share, By Disease pathology, 2022 & 2032
Figure 10: Global Market Y-o-Y Growth Projections, By Disease pathology – 2022-2032
Figure 11: Global Market Attractiveness Index, By Disease pathology – 2022-2032
Figure 12: Global Market Share, By Region, 2022 & 2032
Figure 13: Global Market Y-o-Y Growth Projections, By Region – 2022-2032
Figure 14: Global Market Attractiveness Index, By Region – 2022-2032
Figure 15: North America Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 16: North America Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 17: North America Market Share, Type, 2022 & 2032
Figure 18: North America Market Y-o-Y Growth Projections, Type – 2022-2032
Figure 19: North America Market Attractiveness Index, Type – 2022-2032
Figure 20: North America Market Share, By End-User, 2022 & 2032
Figure 21: North America Market Y-o-Y Growth Projections, By End-User – 2022-2032
Figure 22: North America Market Attractiveness Index, By End-User – 2022-2032
Figure 23: North America Market Share, By Disease pathology, 2022 & 2032
Figure 24: North America Market Y-o-Y Growth Projections, By Disease pathology – 2022-2032
Figure 25: North America Market Attractiveness Index, By Disease pathology – 2022-2032
Figure 26: North America Market Share, By Country, 2022 & 2032
Figure 27: North America Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 28: North America Market Attractiveness Index, By Country – 2022-2032
Figure 29: Latin America Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 30: Latin America Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 31: Latin America Market Share, Type, 2022 & 2032
Figure 32: Latin America Market Y-o-Y Growth Projections, Type – 2022-2032
Figure 33: Latin America Market Attractiveness Index, Type – 2022-2032
Figure 34: Latin America Market Share, By End-User, 2022 & 2032
Figure 35: Latin America Market Y-o-Y Growth Projections, By End-User – 2022-2032
Figure 36: Latin America Market Attractiveness Index, By End-User – 2022-2032
Figure 37: Latin America Market Share, By Disease pathology, 2022 & 2032
Figure 38: Latin America Market Y-o-Y Growth Projections, By Disease pathology – 2022-2032
Figure 39: Latin America Market Attractiveness Index, By Disease pathology – 2022-2032
Figure 40: Latin America Market Share, By Country, 2022 & 2032
Figure 41: Latin America Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 42: Latin America Market Attractiveness Index, By Country – 2022-2032
Figure 43: Europe Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 44: Europe Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 45: Europe Market Share, Type, 2022 & 2032
Figure 46: Europe Market Y-o-Y Growth Projections, Type – 2022-2032
Figure 47: Europe Market Attractiveness Index, Type – 2022-2032
Figure 48: Europe Market Share, By End-User, 2022 & 2032
Figure 49: Europe Market Y-o-Y Growth Projections, By End-User – 2022-2032
Figure 50: Europe Market Attractiveness Index, By End-User – 2022-2032
Figure 51: Europe Market Share, By Disease pathology, 2022 & 2032
Figure 52: Europe Market Y-o-Y Growth Projections, By Disease pathology – 2022-2032
Figure 53: Europe Market Attractiveness Index, By Disease pathology – 2022-2032
Figure 54: Europe Market Share, By Country, 2022 & 2032
Figure 55: Europe Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 56: Europe Market Attractiveness Index, By Country – 2022-2032
Figure 57: MEA Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 58: MEA Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 59: MEA Market Share, Type, 2022 & 2032
Figure 60: MEA Market Y-o-Y Growth Projections, Type – 2022-2032
Figure 61: MEA Market Attractiveness Index, Type – 2022-2032
Figure 62: MEA Market Share, By End-User, 2022 & 2032
Figure 63: MEA Market Y-o-Y Growth Projections, By End-User – 2022-2032
Figure 64: MEA Market Attractiveness Index, By End-User – 2022-2032
Figure 65: MEA Market Share, By Disease pathology, 2022 & 2032
Figure 66: MEA Market Y-o-Y Growth Projections, By Disease pathology – 2022-2032
Figure 67: MEA Market Attractiveness Index, By Disease pathology – 2022-2032
Figure 68: MEA Market Share, By Country, 2022 & 2032
Figure 69: MEA Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 70: MEA Market Attractiveness Index, By Country – 2022-2032
Figure 71: Asia Pacific Market Value (US$ Mn) and Year-on-Year Growth, 2015-2030
Figure 72: Asia Pacific Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 73: Asia Pacific Market Share, Type, 2022 & 2032
Figure 74: Asia Pacific Market Y-o-Y Growth Projections, Type – 2022-2032
Figure 75: Asia Pacific Market Attractiveness Index, Type – 2022-2032
Figure 76: Asia Pacific Market Share, By End-User, 2022 & 2032
Figure 77: Asia Pacific Market Y-o-Y Growth Projections, By End-User – 2022-2032
Figure 78: Asia Pacific Market Attractiveness Index, By End-User – 2022-2032
Figure 79: Asia Pacific Market Share, By Disease pathology, 2022 & 2032
Figure 80: Asia Pacific Market Y-o-Y Growth Projections, By Disease pathology – 2022-2032
Figure 81: Asia Pacific Market Attractiveness Index, By Disease pathology – 2022-2032
Figure 82: Asia Pacific Market Share, By Country, 2022 & 2032
Figure 83: Asia Pacific Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 84: Asia Pacific Market Attractiveness Index, By Country – 2022-2032
Figure 85: US Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 86: US Market Share, Type, 2021
Figure 87: US Market Share, By End-User, 2021
Figure 88: US Market Share, By Disease pathology, 2021
Figure 89: Canada Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 90: Canada Market Share, Type, 2021
Figure 91: Canada Market Share, By End-User, 2021
Figure 92: Canada Market Share, By Disease pathology, 2021
Figure 93: Brazil Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 94: Brazil Market Share, Type, 2021
Figure 95: Brazil Market Share, By End-User, 2021
Figure 96: Brazil Market Share, By Disease pathology, 2021
Figure 97: Mexico Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 98: Mexico Market Share, Type, 2021
Figure 99: Mexico Market Share, By End-User, 2021
Figure 100: Mexico Market Share, By Disease pathology, 2021
Figure 101: Germany Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 102: Germany Market Share, Type, 2021
Figure 103: Germany Market Share, By End-User, 2021
Figure 104: Germany Market Share, By Disease pathology, 2021
Figure 105: U.K. Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 106: U.K. Market Share, Type, 2021
Figure 107: U.K. Market Share, By End-User, 2021
Figure 108: U.K. Market Share, By Disease pathology, 2021
Figure 109: France Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 110: France Market Share, Type, 2021
Figure 111: France Market Share, By End-User, 2021
Figure 112: France Market Share, By Disease pathology, 2021
Figure 113: Italy Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 114: Italy Market Share, Type, 2021
Figure 115: Italy Market Share, By End-User, 2021
Figure 116: Italy Market Share, By Disease pathology, 2021
Figure 117: BENELUX Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 118: BENELUX Market Share, Type, 2021
Figure 119: BENELUX Market Share, By End-User, 2021
Figure 120: BENELUX Market Share, By Disease pathology, 2021
Figure 121: Nordic Countries Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 122: Nordic Countries Market Share, Type, 2021
Figure 123: Nordic Countries Market Share, By End-User, 2021
Figure 124: Nordic Countries Market Share, By Disease pathology, 2021
Figure 125: China Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 126: China Market Share, Type, 2021
Figure 127: China Market Share, By End-User, 2021
Figure 128: China Market Share, By Disease pathology, 2021
Figure 129: Japan Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 130: Japan Market Share, Type, 2021
Figure 131: Japan Market Share, By End-User, 2021
Figure 132: Japan Market Share, By Disease pathology, 2021
Figure 133: South Korea Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 134: South Korea Market Share, Type, 2021
Figure 135: South Korea Market Share, By End-User, 2021
Figure 136: South Korea Market Share, By Disease pathology, 2021
Figure 137: GCC Countries Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 138: GCC Countries Market Share, Type, 2021
Figure 139: GCC Countries Market Share, By End-User, 2021
Figure 140: GCC Countries Market Share, By Disease pathology, 2021
Figure 141: South Africa Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 142: South Africa Market Share, Type, 2021
Figure 143: South Africa Market Share, By End-User, 2021
Figure 144: South Africa Market Share, By Disease pathology, 2021
Figure 145: Turkey Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 146: Turkey Market Share, Type, 2021
Figure 147: Turkey Market Share, By End-User, 2021
Figure 148: Turkey Market Share, By Disease pathology, 2021
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
